TAK-653

TAK-653 · Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAK-653, covering 2019-02-08 to 2020-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Central Nervous System (CNS) Pharmacodynamic Activity of TAK-653 in Healthy Participants Using Transcranial Magnetic Stimulation (TMS) [Phase 1]

See pricing